Insight into the Paradigm of Open Innovation in the Face of the COVID Crisis-19

Author:

Kia Kojouri Karim1ORCID

Affiliation:

1. Department of Management, Bandar Anzali Branch of Islamic Azad University, Bandar Anzali, Iran

Abstract

The corona virus, as a pandemic disease, has exposed the world to difficult and critical conditions. In the meantime, the health service delivery system is at the forefront of confronting and controlling this crisis. Given the special circumstances of the crisis and the threat to public health in Iran, the need for creativity and innovation to manage the corona crisis is more pressing than ever. Open innovation is a phenomenon that has a significant impact on the innovation cycle, increasing research and development costs as well as scarcity of resources. By leveraging these benefits and using new ideas, we might be able to manage crises and reduce damage, especially the COVID -19 crisis.The open innovation paradigm emphasizes the success of the organization by using external and internal ideas. The basic idea behind open innovation is that there is an extensive knowledge that an organization cannot access all through its own proprietary research. So, it must leverage other research through the licensing, patenting process or purchase from other companies. In this model, organizations outsource some parts of the R&D process, use external ideas, constantly monitor the new products of competitors and leading companies, and in some cases collaborate with competitors and other research centers.1, 2 In the process of innovation, studies show that the field of health and treatment has taken on an open nature, and partnership with external organizations has become a key factor and a vital capability.3,4 In this way, valuable ideas can originate from outside the organization and the process of successful activity can be achieved through partnerships with external factors.5 Open innovation has a wide meaning in the field of health, 6 which is mentioned below: Technical and clinical innovations: New therapeutic drugs, diagnostic tests, medical devices, software, surgical techniques Process and service innovations: institutions, business models, service models, clinical pathways, roles, education System innovations: Policy innovation, reform of systems

Publisher

Maad Rayan Publishing Company

Subject

General Medicine

Reference13 articles.

1. Chebrough H. open innovation: the new imperative for creating and profiting from technology, Harvard business press. 2006.

2. Madhoshi M, Kia Kojouri K. Identifying barriers to open innovation in universities. Journal of Research on Management of Teaching in Marine Sciences 2018;4(4):1-5. (Persian).

3. Innovation in Healthcare: A Systematic Review of Recent Research

4. Cross-Pollination in Science and Technology: Concept Mobility in the Nanobiotechnology Field

5. European SMEs’ engagement in open innovation When the important thing is to win and not just to participate, what should innovation policy do?

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3